Exponent, Inc. (NASDAQ:EXPO) Stake Boosted by Geneva Capital Management LLC

Geneva Capital Management LLC increased its stake in Exponent, Inc. (NASDAQ:EXPOFree Report) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,590,804 shares of the business services provider’s stock after purchasing an additional 27,339 shares during the quarter. Exponent makes up approximately 3.1% of Geneva Capital Management LLC’s investment portfolio, making the stock its 4th biggest position. Geneva Capital Management LLC’s holdings in Exponent were worth $183,388,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of EXPO. Quarry LP bought a new position in Exponent in the 2nd quarter worth $25,000. GAMMA Investing LLC raised its holdings in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after acquiring an additional 153 shares during the period. Whittier Trust Co. of Nevada Inc. raised its holdings in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after acquiring an additional 323 shares during the period. USA Financial Formulas bought a new stake in Exponent during the third quarter valued at about $60,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in Exponent by 70.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after acquiring an additional 361 shares during the period. 92.37% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the transaction, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares in the company, valued at $565,494.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now owns 80,742 shares of the company’s stock, valued at $8,445,613.20. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Separately, Truist Financial reissued a “buy” rating and set a $120.00 price target (up from $100.00) on shares of Exponent in a report on Friday, July 26th.

Get Our Latest Stock Report on EXPO

Exponent Price Performance

Shares of Exponent stock traded down $1.42 during trading on Tuesday, reaching $104.81. 25,319 shares of the stock traded hands, compared to its average volume of 245,291. The company has a market capitalization of $5.32 billion, a price-to-earnings ratio of 51.32 and a beta of 0.69. The business has a fifty day simple moving average of $107.60 and a two-hundred day simple moving average of $101.90. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a $0.28 dividend. The ex-dividend date is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 1.07%. Exponent’s dividend payout ratio is currently 54.11%.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.